Health

FDA Approves Talzenna Plus Xtandi for Earlier-Stage Metastatic Prostate Cancer With DNA-Repair Gene Mutations

The FDA approved Pfizer's Talzenna with Xtandi for men with metastatic prostate cancer that still responds to hormone therapy and carries DNA-repair gene mutations.

Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Merck and Moderna Phase 3 Trial

Merck and Moderna's personalized mRNA therapy intismeran, added to Keytruda, cut the risk of melanoma returning or death by 42% in a phase 3 trial presented at ESMO.

FDA Approves Awiqli, the First Once-Weekly Insulin for Children With Type 2 Diabetes

The FDA approved Novo Nordisk's Awiqli for children 10 and older with type 2 diabetes, the first insulin for kids that is injected just once a week.

Flu Hospitalizations Hit Highest Mid-October Rate Since 2010 as CDC Flags Early Season and a New H5N1 Case

Flu hospitalizations are at the highest mid-October rate since 2010-11, CDC data show, with seniors hit hardest, H1N1 dominant and a new H5N1 case in Washington.

Uninsured Rate for Working-Age Adults Jumps to 11.2% Before 2027 Medicaid Cuts, Commonwealth Fund Survey Finds

The uninsured rate for working-age adults rose to 11.2% in 2026 before Medicaid cuts begin, and half skipped care due to cost, Commonwealth Fund finds.

Popular